sb 203580 has been researched along with oxytocin in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (oxytocin) | Trials (oxytocin) | Recent Studies (post-2010) (oxytocin) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 21,611 | 1,831 | 5,773 |
Protein | Taxonomy | sb 203580 (IC50) | oxytocin (IC50) |
---|---|---|---|
Oxytocin receptor | Homo sapiens (human) | 0.0027 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Almeida-Pereira, G; Antunes-Rodrigues, J; Cognuck, SQ; Coletti, R; Elias, LLK; Silva, HVP; Vilhena-Franco, T | 1 |
1 other study(ies) available for sb 203580 and oxytocin
Article | Year |
---|---|
17β-Estradiol attenuates p38MAPK activity but not PKCα induced by angiotensin II in the brain.
Topics: Angiotensin II; Animals; Benzophenanthridines; Brain; Drinking; Drug Interactions; Estradiol; Female; Homeostasis; Imidazoles; MAP Kinase Signaling System; Ovariectomy; Oxytocin; p38 Mitogen-Activated Protein Kinases; Protein Kinase C-alpha; Pyridines; Rats, Wistar; Vasopressins | 2019 |